Novel styrene-based copolymers incorporating alpha-methyl styrene and oxygen-derived peroxide linkages to enable tunable thermal and photodegradation while preserving mechanical performance for disposable foam and paper-plate applications.
This research proposes a new class of degradable styrene-based copolymers designed to replace conventional polystyrene in disposable products such as foam cups and paper plates. By copolymerizing styrene with alpha-methyl styrene (AMS) and incorporating oxygen, the resulting polymer contains interspersed weak peroxide linkages that enable controlled degradation without sacrificing mechanical strength. The approach avoids lactones or lactides and instead leverages the low ceiling temperature of poly(AMS) to introduce thermally and photolytically cleavable sites along the polymer chain. Composition and molecular weight can be tuned to balance performance with degradation rate, and fluorinated styrene or acrylate comonomers can be introduced to improve water repellency and surface appearance.
This concept is at an early research stage. The underlying chemistry—copolymerization of styrene with AMS, O2, and maleic anhydride, and the formation of polymer peroxides—has been demonstrated in prior literature but has not been evaluated for foam or paper-plate applications. Future work will involve controlled radical copolymerization studies, synthesis of structure–property relationships linking mechanical and degradation behavior to molecular weight, composition, and architecture, and incorporation of fluorinated monomers to enhance water repellency. The technology requires further synthesis optimization and property validation before commercial readiness can be assessed.
UConn is a comprehensive public research university and the state’s flagship, with its main campus in Storrs and an academic medical center in Farmington. Industry engages through UConn Tech Park—anchored by the Innovation Partnership Building—with shared labs, pilot‑scale testbeds, and advanced prototyping for collaborators. Integration with UConn Health enables clinical collaborations and translation, while Hartford and Stamford campuses connect companies to talent along the New York–Boston corridor; a statewide extension network supports technology adoption. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, and DOD. A dedicated technology commercialization office and the Technology Incubation Program support IP, licensing, and startup incubation across multiple sites.